核受体亚家族1组D成员1调控NLRP3炎症小体的昼夜节律活性以减轻小鼠暴发性肝炎的严重程度
研究在小鼠和人原代巨噬细胞中探讨核心时钟成分NR1D1对NLRP3炎症小体表达和活性的调控。结果表明NR1D1调控NLRP3表达的昼夜节律及炎症因子产生,激活NR1D1可减轻小鼠暴发性肝炎的严重程度并延长生存时间。
要点
- NR1D1调控巨噬细胞NLRP3炎症小体表达的昼夜节律及IL1B、IL18产生。
- Nr1d1缺失小鼠发生更严重的急性腹膜炎症和暴发性肝炎。
- SR9009激活NR1D1可减轻小鼠肝衰竭并延长生存时间。
核心结论
- NR1D1调控巨噬细胞NLRP3表达的时间节律及炎症因子产生,激活NR1D1可减轻小鼠腹膜炎症和暴发性肝炎的严重程度。
研究设计与样本
- 研究收集Nr1d1-/-小鼠及其Nr1d1+/+同窝对照小鼠多个时间点的腹腔巨噬细胞和血浆,并采用骨髓来源原代巨噬细胞及人原代巨噬细胞进行体外实验。
- 通过小发夹RNA敲低人原代巨噬细胞NR1D1,用脂多糖诱导NLRP3、IL1B和IL18表达,用脂多糖加三磷酸腺苷激活NLRP3复合物,并分析caspase 1活性和细胞因子分泌。
- 用SR9009激活小鼠和人原代巨噬细胞NR1D1,部分细胞同时加入NLRP3抑制剂或caspase 1抑制剂。
- Nr1d1-/-小鼠和对照小鼠腹腔注射脂多糖诱导腹膜炎症,检测血浆细胞因子水平。
- Nr1d1-/-小鼠、对照小鼠及注射SR9009的对照小鼠给予脂多糖和D-半乳糖胺诱导暴发性肝炎,并给予MCC950特异性抑制NLRP3,检测血浆细胞因子和肝衰竭标志物丙氨酸氨基转移酶,肝组织行定量聚合酶链反应、免疫组化和流式细胞术分析。
主要发现
- 腹腔巨噬细胞中NLRP3的表达及其复合物的激活随时间变化呈现昼夜节律,该调控需要NR1D1。
- 与表达NR1D1的巨噬细胞相比,Nr1d1-/-小鼠原代巨噬细胞和敲低NR1D1的人巨噬细胞NLRP3表达模式改变,IL1B和IL18产生模式也改变。
- Nr1d1缺失小鼠发生比对照小鼠更严重的急性腹膜炎症和暴发性肝炎。
- SR9009孵育巨噬细胞可降低NLRP3表达和细胞因子分泌。
- 给予SR9009的小鼠发生比生理盐水对照组更轻的肝衰竭,且生存时间更长。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it is not clear whether these changes affect the activity of the NLRP3 inflammasome. We investigated whether the core clock component nuclear receptor subfamily 1 group D member 1 (NR1D1, also called Rev-erbα) regulates expression, activity of the NLRP3 inflammasome, and its signaling pathway. METHODS: We collected naïve peritoneal macrophages and plasma, at multiple times of day, from Nr1d1-/- mice and their Nr1d1+/+ littermates (controls) and analyzed expression NLRP3, interleukin 1β (IL1B, in plasma), and IL18 (in plasma). We also collected bone marrow-derived primary macrophages from these mice. Levels of NR1D1 were knocked down with small hairpin RNAs in human primary macrophages. Bone marrow-derived primary macrophages from mice and human primary macrophages were incubated with lipopolysaccharide (LPS) to induce expression of NLRP3, IL1B, and IL18; cells were incubated with LPS and adenosine triphosphate to activate the NLRP3 complex. We analyzed caspase 1 activity and cytokine secretion. NR1D1 was activated in primary mouse and human macrophages by incubation with SR9009; some of the cells were also incubated with an NLRP3 inhibitor or inhibitors of caspase 1. Nr1d1-/- mice and control mice were given intraperitoneal injections of LPS to induce peritoneal inflammation; plasma samples were isolated and levels of cytokines were measured. Nr1d1-/- mice, control mice, and control mice given injections of SR9009 were given LPS and D-galactosamine to induce fulminant hepatitis and MCC950 to specifically inhibit NLRP3; plasma was collected to measure cytokines and a marker of liver failure (alanine aminotransferase); liver tissues were collected and analyzed by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry. RESULTS: In peritoneal macrophages, expression of NLRP3 and activation of its complex varied with time of day (circadian rhythm)-this regulation required NR1D1. Primary macrophages from Nr1d1-/- mice and human macrophages with knockdown of NR1D1 had altered expression patterns of NLRP3, compared to macrophages that expressed NR1D1, and altered patterns of IL1B and 1L18 production. Mice with disruption of Nr1d1 developed more-severe acute peritoneal inflammation and fulminant hepatitis than control mice. Incubation of macrophage with the NR1D1 activator SR9009 reduced expression of NLRP3 and secretion of cytokines. Mice given SR9009 developed less-severe liver failure and had longer survival times than mice given saline (control). CONCLUSIONS: In studies of Nr1d1-/- mice and human macrophages with pharmacologic activation of NR1D1, we found NR1D1 to regulate the timing of NLRP3 expression and production of inflammatory cytokines by macrophages. Activation of NR1D1 reduced the severity of peritoneal inflammation and fulminant hepatitis in mice.
引用
- Pourcet B, Zecchin M, Ferri L, et al. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice. Gastroenterology. 2017. PMID: 29277561. doi:10.1053/j.gastro.2017.12.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。